SCHEDULE 13G/A: Kennerman Associates and Christopher Grosso Disclose Significant Stakes in International Isotopes Inc.

Kennerman Associates, Inc. and its principal, Christopher Grosso, have filed an updated Schedule 13G, revealing their combined beneficial ownership of 42.4% and 12.1% respectively, in International Isotopes Inc. as of December 31, 2024.

Summary

• Kennerman Associates, Inc. beneficially owns 234,864,948 shares, representing 42.4% of International Isotopes Inc.'s common stock.
• This includes 4,000,000 shares from vested stock options exercisable within 60 days of December 31, 2024, and 26,300,000 shares issuable upon conversion of Series C Convertible Redeemable Preferred Stock.
• Christopher Grosso beneficially owns 64,833,235 shares, representing 12.1% of the common stock.
• Grosso's ownership includes 4,000,000 shares from vested stock options and 5,040,000 shares from Series C Preferred Stock conversion under sole voting power.
• Grosso also has shared voting power over 4,831,428 shares, including 1,958,928 common shares and 2,000,000 Series C Preferred conversion shares held by his father, and 522,500 common shares and 350,000 Series C Preferred conversion shares held by his son.
• The percentages are based on 523,706,140 shares of common stock outstanding as of February 26, 2025, as reported in the issuer's Annual Report on Form 10-K.

Sentiment

Score: 6

Explanation: The filing indicates a significant and continued beneficial ownership by a major investment entity and its principal, which can be viewed as a positive signal of confidence. However, it is a routine disclosure and does not contain new operational or financial performance data.

Positives

• Significant beneficial ownership by Kennerman Associates, Inc. (42.4%) and Christopher Grosso (12.1%) indicates a strong, long-term interest in International Isotopes Inc.
• The inclusion of shares from vested stock options and convertible preferred stock suggests a commitment to the company's future and potential for increased voting power.

Negatives

• No direct negatives are presented in a Schedule 13G filing, as it primarily serves as a disclosure of ownership.

Risks

• Christopher Grosso disclaims beneficial ownership of 170,186,913 shares owned by various investment advisory clients of Kennerman Associates, Inc., which could imply a complex ownership structure or potential for future changes in control if these shares were to be consolidated or divested.

Future Outlook

NA

Industry Context

This Schedule 13G filing provides an update on significant beneficial ownership in International Isotopes Inc., a company operating in the isotopes industry. While the filing itself does not offer industry-specific trends, the substantial stake held by Kennerman Associates, Inc. and Christopher Grosso could signal confidence in the company's position or future prospects within its specialized sector.

Comparison to Industry Standards

• NA

Related Party Transactions

• Christopher Grosso shares investment control over certain shares held by his father (1,958,928 common shares and 2,000,000 Series C Preferred conversion shares) and his son (522,500 common shares and 350,000 Series C Preferred conversion shares).

Stakeholder Impact

• Shareholders: Provides transparency regarding significant beneficial owners and their respective stakes, which can influence investor perception and confidence.
• Management: Awareness of major shareholders and their potential influence on corporate decisions.

Next Steps

• NA

Key Dates

Keywords

International Isotopes Inc., Kennerman Associates Inc., Christopher Grosso, Schedule 13G, Beneficial Ownership, Common Stock, Series C Preferred Stock, Stock Options, Institutional Investor, Ownership Disclosure, SEC Filing, 45972C102